Genomics

Dataset Information

0

Resolution of Cystic Fibrosis Lung Disease and Inflammation Driven by Mucus Obstruction with Resolvin D1


ABSTRACT: Progressive lung disease remains the major cause of morbidity and mortality of people with cystic fibrosis (CF). CF lung disease evolves from mucus obstruction into non-resolving airway inflammation, bronchiectasis, and damage that impairs respiratory and fitness activity. Therefore, therapeutic strategies that promote resolution of airway inflammation in CF to alleviate the burden of airflow obstruction and improve physical capacity are of wide interest. Here, we report that the proresolving lipid mediator resolvin (Rv) D1 halts mucus-driven inflammation in CF human cells and in vivo. RvD1 dampened migration and pathogenic phenotypes of neutrophils from volunteers with CF as well as inflammatory signaling pathways of CF bronchial epithelial cells triggered by CF mucus. In mice overexpressing the β-subunit of the epithelial Na+ channel (βENaC) RvD1 administration prevented and reverted lung inflammation caused by mucus accumulation and promoted the resolution of pulmonary exacerbation caused by P. aeruginosa. RvD1 also significantly improved physical activity and energy expenditure that are impaired in βENaC mice compared to wild type littermates. These findings demonstrate efficacy of RvD1 in enhancing resolution of lung disease and chronic inflammation associated with mucus obstruction and provide proof of concept for its potential therapeutic approach in FC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE234839 | GEO | 2023/10/10

REPOSITORIES: GEO

Similar Datasets

2023-06-22 | PXD041844 | Pride
2021-11-16 | GSE185849 | GEO
2014-09-11 | E-GEOD-47546 | biostudies-arrayexpress
2010-09-17 | E-GEOD-21071 | biostudies-arrayexpress
2020-03-11 | GSE138716 | GEO
2014-09-11 | GSE47546 | GEO
| phs000596 | dbGaP
2014-07-24 | GSE49373 | GEO
2014-09-11 | E-GEOD-47550 | biostudies-arrayexpress
2010-09-17 | GSE21071 | GEO